Ofloxacin
Ofloxamed is an eye drop solution used to treat infections of the anterior segment of the eye, caused by organisms susceptible to ofloxacin.
Ofloxacin belongs to a group of medicines called quinolone antibacterials.
Before starting to use Ofloxamed, talk to your doctor or pharmacist:
Caution should be exercised when using the medicine in patients with damaged or ulcerated eye surface.
As with other antibiotics, long-term use of Ofloxamed may lead to the growth of non-susceptible pathogenic microorganisms. If such an infection occurs during treatment, the doctor will take appropriate measures.
Tendonitis and tendon rupture have occurred in patients taking fluoroquinolones orally or intravenously, especially in older patients and those treated with corticosteroids at the same time. Treatment with Ofloxamed should be discontinued if pain or inflammation of the tendon (tendinitis) occurs.
Safety and efficacy in infants under one year of age have not been established.
Before using the medicine in children, consult a doctor.
Tell your doctor or pharmacist about all medicines you are taking, or have recently taken, and about medicines you plan to take.
Because systemic exposure to ofloxacin is very low after using Ofloxamed, interactions with other medicines are not expected.
If other eye drops and/or ointments are used at the same time, a minimum interval of 15 minutes should be maintained between administration of the individual medicines. Eye ointments should always be used last.
Inform your doctor if you are pregnant or breastfeeding. Your doctor will advise you whether you can use this medicine.
Using Ofloxamed may cause blurred vision. These symptoms may persist for a few minutes. During this time, do not operate machines, work without strong support, or drive vehicles.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lenses before instillation and wait at least 15 minutes before reinserting.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or disorders affecting the cornea (the transparent layer at the front of the eye). If you experience any abnormal sensations in the eye, stinging, or pain in the eye after using the medicine, consult a doctor.
This medicine should always be used exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
For all patient groups, the recommended dose is:
1 dropof Ofloxamed
If the infection worsens or does not improve after a few days, consult a doctor.
Do not use this medicine for more than 14 days.
Note: If other eye drops and/or ointments are used at the same time, a minimum interval of 15 minutes should be maintained between administration of the individual medicines. Eye ointments should always be used last.
Do not use the contents of the bottle if the tamper-evident seal on the bottle neck is broken before the first use. To open the bottle, unscrew the cap by turning it until the seal is broken.
The medicine should be instilled as follows:
If you have been told to use the medicine in both eyes, repeat the above procedure for the second eye.
Immediately after use, close the bottle tightly with the cap to prevent contamination.
Wipe off any excess liquid from your cheek with a clean cloth.
Proper administration of eye drops is very important. If you are unsure, consult your doctor or pharmacist.
No cases of overdose have been reported.
If systemic side effects occur after incorrect use of the medicine or accidental overdose, systemic treatment should be initiated. In such cases, consult a doctor.
Do not use a double dose to make up for a forgotten dose. Use the forgotten dose as soon as you remember, then continue using the medicine as instructed above or as advised by your doctor.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, Ofloxamed can cause side effects, although not everybody gets them.
If you experience an allergic reaction (including eye allergic reaction), stop using the eye drops and consult a doctor immediately. This side effect is very rare (may affect up to 1 in 10,000 patients).
During treatment with Ofloxamed, life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported, initially appearing as red spots or oval patches on the torso, often with blisters in the center. The frequency of this side effect is unknown (cannot be estimated from available data).
Photosensitivity reactions may also occur, manifesting as conjunctival redness and/or a burning sensation in the eye in response to light. However, these symptoms are usually short-lived. The frequency of this side effect is unknown (cannot be estimated from available data).
The following side effects may also occur:
Rarely (may affect up to 1 in 1,000 patients):
Frequency not known (cannot be estimated from available data):
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: +48 22 49 21 301
fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer packaging and label after "EXP". The expiry date refers to the last day of that month.
Do not use after 4 weeks of opening.
Store the bottle in the outer packaging to protect from light.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Ofloxamed is a clear, yellowish solution.
Each bottle contains 5 ml of eye drop solution.
The product is available in the following pack sizes:
1 x 5 ml
3 x 5 ml
Not all pack sizes may be marketed.
SUN-FARM Sp. z o.o.
ul. Dolna 21
05-092 Łomianki
mibe GmbH Arzneimittel
Münchener Straße 15
06796 Brehna
Germany
Date of last revision of the leaflet:11.2019
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.